Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Support Care Cancer ; 17(1): 3-9, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18386072

RESUMEN

GOALS: The objective of this study was to evaluate the causal attributions for breast cancer and their association with the subsequent psychological adjustment. MATERIALS AND METHODS: Sixty-three Japanese patients newly diagnosed with breast cancer were asked by an interviewer about risk factors and explanations for the etiology of breast cancer using a four-point scale. The General Health Questionnaire (GHQ-28) and the Center for Epidemiologic Studies Depression Scale (CES-D) were administered about 2 months later to measure psychological adjustment to the illness. The relationship between each causal attribution and measure of psychological adjustment was assessed with the Spearman rank correlation after adjusting for potential confounders (age, marital status, cancer stage at diagnosis, time between the day of diagnosis and follow-up, and physical symptoms at the follow-up). MAIN RESULTS: Attributions to several explanations, including "stress" and "personal characteristics," were positively associated with the GHQ-28 measures. Of the attributions to risk factors, "body size" was significantly inversely (r = -0.29) associated and "never having children" was insignificantly and highly inversely (r = -0.77) associated with the GHQ-28 measures, indicating better adjustment to the illness. On the other hand, the attribution to "tobacco" was significantly and positively associated with the GHQ-28 measures (r = 0.34), indicating that the attributions antagonized adjustment to the illness. CONCLUSION: The current study indicates that forming causal attributions influences the adjustment to the illness in Japanese breast cancer patients and attributions to certain risk factors for breast cancer may contribute to better adjustment.


Asunto(s)
Adaptación Psicológica , Actitud Frente a la Salud , Neoplasias de la Mama/psicología , Adulto , Anciano , Pueblo Asiatico/psicología , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/etiología , Recolección de Datos , Femenino , Estudios de Seguimiento , Humanos , Japón/epidemiología , Persona de Mediana Edad , Escalas de Valoración Psiquiátrica , Factores de Riesgo
2.
Cancer Epidemiol Biomarkers Prev ; 17(6): 1418-23, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18559557

RESUMEN

It has been hypothesized that exposure to light at night increases the risk of breast cancer by suppressing the normal nocturnal increase in melatonin production and release, thereby resulting in increased levels of circulating estrogen. We assessed associations among concentrations of serum estrogen and androgen and the principal metabolite of melatonin in urine, 6-sulfatoxymelatonin, and exposure to light at night based on information regarding the sleeping habits and history of graveyard-shift work of 206 postmenopausal Japanese women. Serum estradiol level was significantly higher in women who were not asleep at or after 1:00 a.m. (the approximate time of the melatonin peak) than those who were asleep after controlling for covariates. Significantly increased estrone levels were observed in women who had worked graveyard shift. Serum testosterone and DHEA sulfate were unrelated to sleeping habits and history of graveyard-shift work. Urinary 6-sulfatoxymelatonin was lower in women who were not asleep at or after 1:00 a.m. on weekends than those who were asleep at this time, but the difference was of borderline significance (P = 0.08). There was no significant association between urinary 6-sulfatoxymelatonin and any serum hormone levels. These data suggest that exposure to light at night has implications for the risk of breast cancer in postmenopausal women. However, the potential role of melatonin as an intervening factor between light exposure at night and the serum concentrations of estrogen was equivocal.


Asunto(s)
Andrógenos/sangre , Ritmo Circadiano , Estrógenos/sangre , Luz/efectos adversos , Melatonina/análogos & derivados , Biomarcadores/sangre , Neoplasias de la Mama/etiología , Neoplasias de la Mama/metabolismo , Femenino , Humanos , Japón , Melatonina/sangre , Persona de Mediana Edad , Posmenopausia , Radioinmunoensayo , Factores de Riesgo , Espectrometría de Masa por Ionización de Electrospray , Encuestas y Cuestionarios , Espectrometría de Masas en Tándem , Tolerancia al Trabajo Programado
3.
Nutr Cancer ; 60(1): 49-54, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18444135

RESUMEN

The isoflavone metabolite equol has been identified in urine or blood samples in some but not all humans. In this cross-sectional study, we examined the association between lifestyle, including diet, and the urinary excretion of equol. Study subjects were 419 Japanese women who were recruited from a breast cancer screening center. Each woman responded to a self-administered questionnaire seeking information about health and lifestyle factors. Diet was assessed by a validated semiquantitative food frequency questionnaire. Urinary isoflavones were measured using spot urine samples. Equol was detected in the urine of 84 (20.0%) women. After controlling for covariates, it was found that dairy product intake was significantly lower in those who excreted detectable equol levels in urine than in those who did not. Because equol is derived from daidzein, individuals with low intake of daidzein may produce undetectable levels of equol. To account for this, the study subjects were restricted to 163 women with urinary daidzein levels of 10 nmol/mg creatinine or higher. The association of equol excretion with dairy product intake remained significant. Demographic factors, smoking status, and menstrual and reproductive factors were unrelated to equol excretion. These data suggest that dairy product intake may be associated with the production of equol.


Asunto(s)
Productos Lácteos , Dieta , Isoflavonas/orina , Estilo de Vida , Neoplasias de la Mama/diagnóstico , Estudios de Casos y Controles , Estudios Transversales , Productos Lácteos/efectos adversos , Equol , Femenino , Humanos , Isoflavonas/metabolismo , Japón , Ciclo Menstrual , Persona de Mediana Edad , Posmenopausia , Fumar , Encuestas y Cuestionarios
4.
Cancer Epidemiol Biomarkers Prev ; 16(11): 2509-12, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18006946

RESUMEN

A protective role of melatonin in the etiology of breast cancer has been suggested. The down-regulation of estrogen secretion by melatonin is thought to be a main cause of the link between melatonin and breast cancer risk. The present cross-sectional study examined whether the urinary 6-sulfatoxymelatonin (aMT6-s) level is inversely associated with mammographic density, which is regarded as a marker of breast cancer risk. The study subjects were 289 Japanese women (175 premenopausal and 123 postmenopausal women) who were recruited from participants in a mammographic breast cancer screening. The size of the total breast area and that of the dense area were measured quantitatively using an automated mammographic mass detection method. The concentration of aMT6-s was measured using first-void morning urine. In premenopausal women, the urinary aMT6-s level was significantly positively associated with percent density after controlling for covariates (P for trend=0.02). There was no significant association between urinary aMT6-s level and the percent density in postmenopausal women. We found no evidence that the melatonin level is inversely associated with mammographic density.


Asunto(s)
Neoplasias de la Mama/orina , Melatonina/análogos & derivados , Adulto , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/patología , Estudios Transversales , Femenino , Humanos , Japón/epidemiología , Mamografía , Melatonina/orina , Menopausia/orina , Persona de Mediana Edad
5.
Cancer Epidemiol Biomarkers Prev ; 14(12): 2877-80, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16365004

RESUMEN

BACKGROUND: A high percentage of mammographic dense area has been strongly associated with a risk of beast cancer. The present cross-sectional study evaluated the relations of percent density with dietary factors, such as fats, protein, dietary fiber, and soy isoflavones. METHODS: Study subjects were 601 (348 premenopausal and 253 postmenopausal) Japanese women who were recruited from a mammographic screening center. The size of the total breast area and the dense area were measured quantitatively using an automated mammographic mass detection method. Intakes of nutrients were estimated with a validated semiquantitative food-frequency questionnaire. RESULTS: The crude means of the percent density were 39.2% and 18.9% in premenopausal and postmenopausal women, respectively. There were no significant associations of any dietary factors with the percent density in premenopausal women. In postmenopausal women, percent density was significantly positively associated with intakes of protein, total fat, and saturated fat after controlling for covariates; the increase in the means of percent density were 7.2%, 5.6%, and 9.2% in the highest versus lowest quartile of intakes for protein, total fat, and saturated fat, respectively (P for linear trend were 0.006, 0.04, and 0.01, respectively). Carbohydrate intake was inversely associated with percent density; the mean of percent density was 6.0% lower in the highest versus the lowest quartile of intake (P(trend) = 0.03). The associations of dietary factors with dense area were very similar to those with percent density. CONCLUSION: These dietary factors may have implications for the risk of breast cancer in postmenopausal women.


Asunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Mama/patología , Dieta , Adulto , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/patología , Estudios Transversales , Registros de Dieta , Femenino , Humanos , Japón/epidemiología , Mamografía , Persona de Mediana Edad , Posmenopausia , Premenopausia , Factores de Riesgo
6.
J Nutr ; 135(12): 2862-5, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16317133

RESUMEN

A reduction in fat intake has been associated with decreased estrogen levels in dietary intervention studies. However, previous cross-sectional studies conducted mainly among Western populations did not find a positive association between fat intake and postmenopausal estrogen levels. This study examined the cross-sectional association of fat intake with serum levels of estrone, estradiol, testosterone, and dehydroepiandrosterone sulfate (DHEAS) in women. Study subjects were 324 healthy postmenopausal Japanese women. Diet including fat intake was assessed by a validated semiquantitative FFQ. After controlling for age and other potential breast cancer risk factors, serum estrone was positively associated with the percentage of energy from total fat (P = 0.04). The associations of serum estrone with monounsaturated fat and polyunsaturated fat were of borderline significance (P = 0.05). Serum DHEAS was positively associated with the percentage of energy from total fat (P = 0.007), saturated fat (P = 0.009), monounsaturated fat (P = 0.006), and polyunsaturated fat (P = 0.04). Serum estrone and DHEAS concentrations increased 11.8 and 9.3%, respectively, with a 5% increase in the percentage of energy from total fat. These data suggest that a high intake of fat is associated with higher serum levels of estrone and DHEAS in postmenopausal women.


Asunto(s)
Andrógenos/sangre , Grasas de la Dieta , Estrógenos/sangre , Posmenopausia/fisiología , Adulto , Consumo de Bebidas Alcohólicas , Neoplasias de la Mama/epidemiología , Sulfato de Deshidroepiandrosterona/sangre , Estradiol/sangre , Estrona/sangre , Femenino , Humanos , Japón , Mamografía , Persona de Mediana Edad , Fumar , Testosterona/sangre
7.
Cancer Epidemiol Biomarkers Prev ; 14(5): 1333-5, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15894698

RESUMEN

Melatonin is present in plants consumed as vegetables; however, only a limited number of vegetables have been tested for melatonin. The antiproliferative, antioxidative, and immunostimulatory effects of melatonin have been reported from laboratory studies. The potential protective effects of vegetable against cancer and cardiovascular disease may be partially attributable to an increased melatonin intake from vegetables. As a first step to test this hypothesis, we evaluated whether vegetable intake is associated with an increased urinary melatonin in 289 community-dwelling Japanese women. Diet, including vegetable consumption, was assessed with a validated 169-item semiquantitative food-frequency questionnaire. Urinary 6-sulfatoxymelatonin (aMT6-s) was measured in the first-void morning urines. There was a significant positive association between vegetable intake and urinary aMT6-s levels. The mean urinary aMT6-s was 16% higher in women with the highest quartile of vegetable intake than it was in those with the lowest quartile of intake. This association may be explained by the melatonin contained in vegetables. However, data should be regarded as preliminary because it is impossible to estimate dietary melatonin intake from vegetables and or from the entire diet because of incomplete data for melatonin in plants.


Asunto(s)
Melatonina/análogos & derivados , Verduras/metabolismo , Adulto , Anciano , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/prevención & control , Femenino , Humanos , Japón , Melatonina/orina , Persona de Mediana Edad , Neoplasias/metabolismo , Neoplasias/prevención & control , Evaluación Nutricional , Factores de Riesgo , Factores de Tiempo , Verduras/química , Salud de la Mujer
8.
Cancer Epidemiol Biomarkers Prev ; 14(3): 705-8, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15767353

RESUMEN

BACKGROUND: Recent laboratory studies have suggested that cadmium is an estrogenic compound and may be a potential risk factor for breast cancer. METHODS: We investigated the relationship between urinary cadmium concentrations and serum concentrations of estrone, testosterone, and dehydroepiandrosterone sulfate in 164 postmenopausal Japanese women. RESULTS: There was a significant positive association between the urinary cadmium and serum testosterone levels after controlling for age and body mass index. The mean testosterone level was 28% higher in women with high urinary cadmium (> or = 3.00 microg/g creatinine) than in those with low urinary cadmium (< 2.00 microg/g creatinine). Urinary cadmium was not significantly associated with serum estrone and dehydroepiandrosterone sulfate levels. Additional adjustment for smoking, alcohol and reproductive factors including known risk factors for breast cancer did not substantially alter the results. CONCLUSION: Data suggested that cadmium exposure is associated with increased testosterone levels. As high testosterone levels have been associated with the risk of breast cancer, the involvement of cadmium exposure in breast cancer risk should be evaluated in future studies.


Asunto(s)
Andrógenos/sangre , Neoplasias de la Mama/etiología , Cadmio/orina , Estrógenos/sangre , Anciano , Índice de Masa Corporal , Neoplasias de la Mama/epidemiología , Estudios de Casos y Controles , Femenino , Humanos , Japón/epidemiología , Persona de Mediana Edad , Posmenopausia , Factores de Riesgo
9.
Pathol Int ; 53(2): 102-5, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12588438

RESUMEN

We experienced an extremely rare tumor in the female urethral orifice in a 57-year-old Japanese woman. To our knowledge, only two cases of primary urethral carcinoid tumor have been reported. The previous reports of urethral carcinoid tumor were recognized in the male middle urethra and penile urethra. The present case was resected, and diagnosed as a carcinoid tumor by histological, immunohistochemical and ultrastructural findings. The tumor cells were stained by chromogranin A, synaptophsin and neuron-specific enolase, and neurosecretory granules were confirmed with electron microscopy. The patient did not complain of any symptoms until 5 years after the resection of the tumor. Therefore, the case we describe here is the first known report of carcinoid tumor in the Japanese female urethra.


Asunto(s)
Tumor Carcinoide/patología , Neoplasias Uretrales/patología , Biomarcadores de Tumor/análisis , Tumor Carcinoide/química , Tumor Carcinoide/cirugía , Cromogranina A , Cromograninas/análisis , Femenino , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Vesículas Secretoras/ultraestructura , Sinaptofisina/análisis , Resultado del Tratamiento , Neoplasias Uretrales/química , Neoplasias Uretrales/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA